These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22566505)

  • 1. Increased cerebral metabolism after 1 year of deep brain stimulation in Alzheimer disease.
    Smith GS; Laxton AW; Tang-Wai DF; McAndrews MP; Diaconescu AO; Workman CI; Lozano AM
    Arch Neurol; 2012 Sep; 69(9):1141-8. PubMed ID: 22566505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer's Disease.
    Lozano AM; Fosdick L; Chakravarty MM; Leoutsakos JM; Munro C; Oh E; Drake KE; Lyman CH; Rosenberg PB; Anderson WS; Tang-Wai DF; Pendergrass JC; Salloway S; Asaad WF; Ponce FA; Burke A; Sabbagh M; Wolk DA; Baltuch G; Okun MS; Foote KD; McAndrews MP; Giacobbe P; Targum SD; Lyketsos CG; Smith GS
    J Alzheimers Dis; 2016 Sep; 54(2):777-87. PubMed ID: 27567810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep Brain Stimulation Influences Brain Structure in Alzheimer's Disease.
    Sankar T; Chakravarty MM; Bescos A; Lara M; Obuchi T; Laxton AW; McAndrews MP; Tang-Wai DF; Workman CI; Smith GS; Lozano AM
    Brain Stimul; 2015; 8(3):645-54. PubMed ID: 25814404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of STN DBS on vesicular monoamine transporter 2 and glucose metabolism in Parkinson's disease.
    Smith GS; Mills KA; Pontone GM; Anderson WS; Perepezko KM; Brasic J; Zhou Y; Brandt J; Butson CR; Holt DP; Mathews WB; Dannals RF; Wong DF; Mari Z
    Parkinsonism Relat Disord; 2019 Jul; 64():235-241. PubMed ID: 31053531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease.
    Laxton AW; Tang-Wai DF; McAndrews MP; Zumsteg D; Wennberg R; Keren R; Wherrett J; Naglie G; Hamani C; Smith GS; Lozano AM
    Ann Neurol; 2010 Oct; 68(4):521-34. PubMed ID: 20687206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep Brain Stimulation Targeting the Fornix for Mild Alzheimer Dementia (the ADvance Trial): A Two Year Follow-up Including Results of Delayed Activation.
    Leoutsakos JS; Yan H; Anderson WS; Asaad WF; Baltuch G; Burke A; Chakravarty MM; Drake KE; Foote KD; Fosdick L; Giacobbe P; Mari Z; McAndrews MP; Munro CA; Oh ES; Okun MS; Pendergrass JC; Ponce FA; Rosenberg PB; Sabbagh MN; Salloway S; Tang-Wai DF; Targum SD; Wolk D; Lozano AM; Smith GS; Lyketsos CG
    J Alzheimers Dis; 2018; 64(2):597-606. PubMed ID: 29914028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral deep brain stimulation of the fornix for Alzheimer's disease: surgical safety in the ADvance trial.
    Ponce FA; Asaad WF; Foote KD; Anderson WS; Rees Cosgrove G; Baltuch GH; Beasley K; Reymers DE; Oh ES; Targum SD; Smith GS; Lyketsos CG; Lozano AM;
    J Neurosurg; 2016 Jul; 125(1):75-84. PubMed ID: 26684775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep brain stimulation of fornix in Alzheimer's disease: From basic research to clinical practice.
    Liu Z; Shu K; Geng Y; Cai C; Kang H
    Eur J Clin Invest; 2023 Aug; 53(8):e13995. PubMed ID: 37004153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Fornix Deep Brain Stimulation Improves Hippocampal Glucose Metabolism in Aged Mice.
    Wang X; Hu WH; Zhang K; Zhou JJ; Liu DF; Zhang MY; Zhang JG
    Chin Med J (Engl); 2018 Mar; 131(5):594-599. PubMed ID: 29483395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep Brain Stimulation of Frontal Lobe Networks to Treat Alzheimer's Disease.
    Scharre DW; Weichart E; Nielson D; Zhang J; Agrawal P; Sederberg PB; Knopp MV; Rezai AR;
    J Alzheimers Dis; 2018; 62(2):621-633. PubMed ID: 29400666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep brain stimulation of the nucleus basalis of Meynert modulates hippocampal-frontoparietal networks in patients with advanced Alzheimer's disease.
    Jiang Y; Yuan TS; Chen YC; Guo P; Lian TH; Liu YY; Liu W; Bai YT; Zhang Q; Zhang W; Zhang JG
    Transl Neurodegener; 2022 Dec; 11(1):51. PubMed ID: 36471370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modifying the progression of Alzheimer's and Parkinson's disease with deep brain stimulation.
    Jakobs M; Lee DJ; Lozano AM
    Neuropharmacology; 2020 Jul; 171():107860. PubMed ID: 31765650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal deep brain stimulation sites and networks for stimulation of the fornix in Alzheimer's disease.
    Ríos AS; Oxenford S; Neudorfer C; Butenko K; Li N; Rajamani N; Boutet A; Elias GJB; Germann J; Loh A; Deeb W; Wang F; Setsompop K; Salvato B; Almeida LB; Foote KD; Amaral R; Rosenberg PB; Tang-Wai DF; Wolk DA; Burke AD; Salloway S; Sabbagh MN; Chakravarty MM; Smith GS; Lyketsos CG; Okun MS; Anderson WS; Mari Z; Ponce FA; Lozano AM; Horn A
    Nat Commun; 2022 Dec; 13(1):7707. PubMed ID: 36517479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep brain stimulation for the treatment of Alzheimer disease and dementias.
    Laxton AW; Lozano AM
    World Neurosurg; 2013; 80(3-4):S28.e1-8. PubMed ID: 22722036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep Brain Stimulation as an Emerging Therapy for Cognitive Decline in Alzheimer Disease: Systematic Review of Evidence and Current Targets.
    Picton B; Wong J; Lopez AM; Solomon SS; Andalib S; Brown NJ; Dutta RR; Paff MR; Hsu FP; Oh MY
    World Neurosurg; 2024 Apr; 184():253-266.e2. PubMed ID: 38141755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal assessment of the neuroanatomical consequences of deep brain stimulation: Application of fornical DBS in an Alzheimer's mouse model.
    Gallino D; Devenyi GA; Germann J; Guma E; Anastassiadis C; Chakravarty MM
    Brain Res; 2019 Jul; 1715():213-223. PubMed ID: 30926457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep brain stimulation of the subcallosal cingulate for treatment-refractory anorexia nervosa: 1 year follow-up of an open-label trial.
    Lipsman N; Lam E; Volpini M; Sutandar K; Twose R; Giacobbe P; Sodums DJ; Smith GS; Woodside DB; Lozano AM
    Lancet Psychiatry; 2017 Apr; 4(4):285-294. PubMed ID: 28238701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive and anatomic contributions of metabolic decline in Alzheimer disease and cerebrovascular disease.
    Kuczynski B; Reed B; Mungas D; Weiner M; Chui HC; Jagust W
    Arch Neurol; 2008 May; 65(5):650-5. PubMed ID: 18474742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral metabolism, cognition, and functional abilities in Alzheimer disease.
    Melrose RJ; Ettenhofer ML; Harwood D; Achamallah N; Campa O; Mandelkern M; Sultzer DL
    J Geriatr Psychiatry Neurol; 2011 Sep; 24(3):127-34. PubMed ID: 21856969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in Nutritional Status after Deep Brain Stimulation of the Nucleus Basalis of Meynert in Alzheimer's Disease--Results of a Phase I Study.
    Noreik M; Kuhn J; Hardenacke K; Lenartz D; Bauer A; Bührle CP; Häussermann P; Hellmich M; Klosterkötter J; Wiltfang J; Maarouf M; Freund HJ; Visser-Vandewalle V; Sturm V; Schulz RJ
    J Nutr Health Aging; 2015 Oct; 19(8):812-8. PubMed ID: 26412285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.